Drug intelligence / Profile preview

ecabet sodium

Development stage
Phase 4
Lead developer
Taisho Pharmaceutical
Modality
Small Molecules
Administration
Oral, Ophthalmic
01

Overview

Ecabet sodium is a small molecule anti-ulcer agent primarily used in Japan for the treatment of gastric ulcers and gastritis. It acts by enhancing the protective barrier of the gastric mucosa, increasing mucus and bicarbonate production to neutralize stomach acid and protect the mucosal lining from damage[1][2]. Additionally, it inhibits pepsin activity, reduces Helicobacter pylori survival in the stomach, and irreversibly inhibits urease—an enzyme critical for H. pylori colonization—by binding to it and causing denaturation[3][4][6][8]. Ecabet also increases mucin production when used as an eye drop for dry eye syndrome by stimulating conjunctival goblet cells and corneal epithelia[3].

Brand names
EcabetEcabet sodium [JAN]
Other names
ecabet monosodiumecabet sodium saltsulfodehydroabietic acid monosodium saltecabetum
02

Targets

MUC5AC (Mucin-5AC)EP1-4 (EP receptor family)NCF1 (Neutrophil cytosolic factor 1)Urease subunit alpha

Beyond the preview

Go deeper on ecabet sodium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ecabet sodium.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call